Episodit
-
Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.
-
Puuttuva jakso?
-
Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.
-
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
-
Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.
-
Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.
-
Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis.
-
Dr. Gustavo Saposnik discusses the efficacy of non-immersive virtual reality exercise in the treatment of stroke.
-
Professor Valery Feigin discusses an Article on the global burden of stroke and risk factors from 1990–2013.
-
Francesc Graus and Josep Dalmau discuss new criteria for a clinical approach for the diagnosis of autoimmune encephalitis.
-
Bas Bloem talks about ParkinsonNet, a healthcare model that supports a multidisciplinary network for people with Parkinson’s disease.
-
Clifford Jack from the Mayo Clinic discusses a research article which investigates the role of biomarkers to help identify preclinical dementia.
-
Chris McDermott and Richard Lane discuss the DiPALS study, investigating the effect of diaphragm pacing in addition to non-invasive ventilation in patients with ALS.
- Näytä enemmän
